Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Turin, Italy.
Univ. Bordeaux, CNRS, CRMSB, UMR 5536, 33000, Bordeaux, France.
Sci Rep. 2023 Aug 22;13(1):13725. doi: 10.1038/s41598-023-40857-4.
This work aims at developing a diagnostic method based on Electron Paramagnetic Resonance (EPR) measurements of stable nitroxide radicals released from "EPR silent" liposomes. The liposome destabilisation and consequent radical release is enzymatically triggered by the action of phospholipase A2 (PLA2) present in the biological sample of interest. PLA2 are involved in a broad range of processes, and changes in their activity may be considered as a unique valuable biomarker for early diagnoses. The minimum amount of PLA2 measured "in vitro" was 0.09 U/mL. Moreover, the liposomes were successfully used to perform Overhauser-enhanced Magnetic Resonance Imaging (OMRI) in vitro at 0.2 T. The amount of radicals released by PLA2 driven liposome destabilization was sufficient to generate a well detectable contrast enhancement in the corresponding OMRI image.
这项工作旨在开发一种基于电子顺磁共振(EPR)测量从“EPR 静默”脂质体中释放的稳定氮氧自由基的诊断方法。脂质体的不稳定性以及随后的自由基释放是由存在于感兴趣的生物样品中的磷脂酶 A2(PLA2)的作用酶促触发的。PLA2 参与广泛的过程,其活性的变化可以被认为是早期诊断的独特有价值的生物标志物。在“体外”测量的最小 PLA2 量为 0.09 U/mL。此外,成功地使用脂质体在 0.2 T 下进行了超极化增强磁共振成像(OMRI)。由 PLA2 驱动的脂质体去稳定化释放的自由基数量足以在相应的 OMRI 图像中产生可检测的对比度增强。